Alterations in cortical network oscillations and parvalbumin neurons in schizophrenia

G Gonzalez-Burgos, RY Cho, DA Lewis - Biological psychiatry, 2015 - Elsevier
Cognitive deficits are a core clinical feature of schizophrenia but respond poorly to available
medications. Thus, understanding the neural basis of these deficits is crucial for the …

The construct of the multisensory temporal binding window and its dysregulation in developmental disabilities

MT Wallace, RA Stevenson - Neuropsychologia, 2014 - Elsevier
Behavior, perception and cognition are strongly shaped by the synthesis of information
across the different sensory modalities. Such multisensory integration often results in …

Brain NMDA receptors in schizophrenia and depression

A Adell - Biomolecules, 2020 - mdpi.com
N-methyl-D-aspartate (NMDA) receptor antagonists such as phencyclidine (PCP),
dizocilpine (MK-801) and ketamine have long been considered a model of schizophrenia …

Spontaneous gamma activity in schizophrenia

Y Hirano, N Oribe, S Kanba, T Onitsuka… - JAMA …, 2015 - jamanetwork.com
Importance A major goal of translational neuroscience is to identify neural circuit
abnormalities in neuropsychiatric disorders that can be studied in animal models to facilitate …

Altered cortical ensembles in mouse models of schizophrenia

JP Hamm, DS Peterka, JA Gogos, R Yuste - Neuron, 2017 - cell.com
In schizophrenia, brain-wide alterations have been identified at the molecular and cellular
levels, yet how these phenomena affect cortical circuit activity remains unclear. We studied …

Targeting reduced neural oscillations in patients with schizophrenia by transcranial alternating current stimulation

S Ahn, JM Mellin, S Alagapan, ML Alexander… - Neuroimage, 2019 - Elsevier
Transcranial alternating current stimulation (tACS) modulates endogenous neural
oscillations in healthy human participants by the application of a low-amplitude electrical …

Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia

MJ Gandal, JC Edgar, K Klook, SJ Siegel - Neuropharmacology, 2012 - Elsevier
The lack of efficacy for antipsychotics with respect to negative symptoms and cognitive
deficits is a significant obstacle for the treatment of schizophrenia. Developing new drugs to …

Discriminating schizophrenia and bipolar disorder by fusing fMRI and DTI in a multimodal CCA+ joint ICA model

J Sui, G Pearlson, A Caprihan, T Adali, KA Kiehl, J Liu… - Neuroimage, 2011 - Elsevier
Diverse structural and functional brain alterations have been identified in both schizophrenia
and bipolar disorder, but with variable replicability, significant overlap and often in limited …

A review of gamma oscillations in healthy subjects and in cognitive impairment

E Başar - International Journal of Psychophysiology, 2013 - Elsevier
This review describes a wide range of functional correlates of gamma oscillations in whole-
brain work, in neuroethology, sensory–cognitive dynamics, emotion, and cognitive …

Differential alterations of auditory gamma oscillatory responses between pre-onset high-risk individuals and first-episode schizophrenia

M Tada, T Nagai, K Kirihara, S Koike, M Suga… - Cerebral …, 2016 - academic.oup.com
Alterations in gamma-band auditory steady-state response (ASSR) are the most robust
finding of abnormal neural oscillations in patients with first-episode (FES) and chronic …